ArticleEye (London, England)2026

Response to: "Comment on: risk of retinal vein occlusions in patients taking systemic tyrosine kinase inhibitors".

Nitesh Mohan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.